US Stock MarketDetailed Quotes

PHAT Phathom Pharmaceuticals

Watchlist
  • 10.390
  • +0.720+7.45%
Close May 14 16:00 ET
  • 10.390
  • 0.0000.00%
Post 19:43 ET
608.18MMarket Cap-2329P/E (TTM)

About Phathom Pharmaceuticals Company

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Company Profile

SymbolPHAT
Company NamePhathom Pharmaceuticals
Listing DateOct 25, 2019
Issue Price19.00
Founded2018
CEOMs. Terrie Curran
MarketNASDAQ
Employees452
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 Campus Drive,Suite 102
CityFlorham Park
ProvinceNew Jersey
CountryUnited States of America
Zip Code07932
Phone1-877-742-8466
Websitehttp://www.phathompharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Terrie Curran
  • President, Chief Executive Officer and Director
  • 3.41M
  • Molly Henderson
  • Chief Financial and Business Officer and Principal Accounting Officer
  • 1.87M
  • Azmi Nabulsi, M.D.
  • Chief Operating Officer
  • 2.04M
  • Michael F. Cola
  • Chairman of the Board
  • 331.34K
  • Frank L. Karbe
  • Independent Director
  • 283.84K
  • David A. Socks
  • Independent Director
  • 266.34K
  • Heidi Kunz
  • Independent Director
  • 287.17K
  • Dr. Asit Parikh, M.D.,PhD
  • Independent Director
  • 279.67K
  • Mark Stenhouse
  • Independent Director
  • 283.84K
  • Dr. James N. Topper, M.D.,PhD
  • Independent Director
  • 267.14K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg